Medica

Throughout the 1980s and 1990s, Clostridium botulinum has been intensively researched by a group of scientist in Korea. In 2000, the scientists established a biotech venture named “Medy-Tox Inc.” which specializes in botulinum and its toxins. Following much research on biological, biochemical, immunological and toxicity aspects, botulinum toxin type A has been developed as a biopharmaceutical product.

What is Neuronox®?

Neuronox is botulinum toxin type A complex (100 uints) manufactured by Medy-Tox Inc.
Neuronox produces partial chemical denervation of the muscle resulting in a localized reduction in muscle activity. In addition, the muscle may atrophy, axonal sprouting may occur, and extra junctional acetlcholine receptors may develop. There is evidence that reinnervation of the muscle may occur, thus slow reversing muscle denervation by Neuronox can be used for therapies
Neuronox is botulinum toxin type A complex (100 uints) manufactured by Medy-Tox Inc.

Why Choosing Neuronox®?

Neuronox has shown excellent results in therapeutic studies as well as cosmetic studies. Customers and partners in more than 50 countries have been using Neuronox.
Taking into account its efficacy, safety, and price compared with competitive products, Neuronox is continually becoming the most welcomed choice of botulinum toxin drug for both doctors and patients in the world.